Oleg Sofrygin
Impact in
- Genetics top 5%
- Hemoglobinopathies and Related Disorders
- Hematology top 5%
- Iron Metabolism and Disorders
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 4
- Genetics 8
- Hemoglobinopathies and Related Disorders 7
- Estrogen and related hormone effects 4
- Co-authors
- Thomas E. Delea (14 shared papers)Simu K. Thomas (7 shared papers)Jean‐François Baladi (4 shared papers)Thomas D. Coates (4 shared papers)Mark J. van der Laan (7 shared papers)Pradyumna D. Phatak (5 shared papers)John Edelsberg (2 shared papers)Gerry Oster (4 shared papers)
- Journals
- Value in Health (3 papers)Journal of Clinical Oncology (3 papers)Blood (3 papers)Clinical Breast Cancer (2 papers)The European Journal of Health Economics (2 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Oleg Sofrygin
45 papers receiving 764 citations
Peers
Comparison fields: 5 of 111
- Genetics 239
- Hematology 228
- Statistics and Probability 102
- Health Informatics 12
- Health 52
Countries citing papers authored by Oleg Sofrygin
This map shows the geographic impact of Oleg Sofrygin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oleg Sofrygin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oleg Sofrygin more than expected).
Fields of papers citing papers by Oleg Sofrygin
This network shows the impact of papers produced by Oleg Sofrygin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oleg Sofrygin. The network helps show where Oleg Sofrygin may publish in the future.
Co-authors
The 25 scholars most cited alongside Oleg Sofrygin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 147 | |
| 2 | 2007 | 70 | |
| 3 | 2013 | 43 | |
| 4 | Cost-effectiveness of abatacept in patients with moderately to severely active rheumatoid arthritis and inadequate response to tumor necrosis factor-alpha antagonists. | 2008 | 42 |
| 5 | 2007 | 37 | |
| 6 | 2022 | 34 | |
| 7 | 2007 | 31 | |
| 8 | 2016 | 30 | |
| 9 | 2018 | 27 | |
| 10 | 2020 | 24 | |
| 11 | 2011 | 22 | |
| 12 | 2007 | 22 | |
| 13 | 2017 | 20 | |
| 14 | 2018 | 20 | |
| 15 | 2009 | 19 | |
| 16 | 2009 | 18 | |
| 17 | 2006 | 14 | |
| 18 | 2017 | 13 | |
| 19 | 2018 | 13 | |
| 20 | 2014 | 12 |
About Oleg Sofrygin
Oleg Sofrygin is a scholar working on Economics and Econometrics, Genetics, Oncology, Pulmonary and Respiratory Medicine and Hematology, having authored 47 papers that have together received 785 indexed citations. Recurring topics across this work include Hemoglobinopathies and Related Disorders (7 papers), Cancer Treatment and Pharmacology (5 papers), Iron Metabolism and Disorders (5 papers), Statistical Methods and Inference (5 papers), Health disparities and outcomes (5 papers), HER2/EGFR in Cancer Research (4 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Estrogen and related hormone effects (4 papers). The work is most often cited by research in Genetics (239 citations), Hematology (228 citations), Statistics and Probability (102 citations), Health Informatics (12 citations) and Health (52 citations). Oleg Sofrygin has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Thomas E. Delea, Simu K. Thomas, Jean‐François Baladi, Thomas D. Coates, Mark J. van der Laan, Pradyumna D. Phatak, John Edelsberg, Gerry Oster, Jonathan Karnon and Kara E. Rudolph. Their work appears in journals such as Value in Health, Journal of Clinical Oncology, Blood, Clinical Breast Cancer and The European Journal of Health Economics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.